Huadong Medicine Co (SZSE:000963) Cash And Cash Equivalents

: ¥3,930 Mil (As of Sep. 2023)

View and export this data going back to 2000. Start your Free Trial

Huadong Medicine Co's quarterly cash and cash equivalents increased from Mar. 2023 (¥2,375.15 Mil) to Jun. 2023 (¥4,393.84 Mil) but then stayed the same from Jun. 2023 (¥4,393.84 Mil) to Sep. 2023 (¥3,930.06 Mil).

Huadong Medicine Co's annual cash and cash equivalents increased from Dec. 2020 (¥3,198.08 Mil) to Dec. 2021 (¥4,032.43 Mil) but then declined from Dec. 2021 (¥4,032.43 Mil) to Dec. 2022 (¥3,996.30 Mil).

Huadong Medicine Co Cash And Cash Equivalents Historical Data

The historical data trend for Huadong Medicine Co's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huadong Medicine Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Cash And Cash Equivalents

2,442.72

2,402.73

3,198.08

4,032.43

3,996.30

Huadong Medicine Co Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Cash And Cash Equivalents																3,175.27	3,996.30	2,375.15	4,393.84	3,930.06

Huadong Medicine Co Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Huadong Medicine Co (SZSE:000963) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Huadong Medicine Co Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Huadong Medicine Co's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Huadong Medicine Co (SZSE:000963) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Huadong Medicine Co Ltd (SZSE:000963) » Definitions » Cash And Cash Equivalents

Traded in Other Exchanges

N/A

Address

468 Yan’an Road, Floor 7, 9 and 10, Gate No. 1, Building No. 1, Hangzhou, CHN, 310006

Website

http://www.eastchinapharm.com

Huadong Medicine Co Ltd is engaged in the production and sales of antibiotics, proprietary Chinese medicine, chemical synthetic medicine and genetic engineering drugs products. It is also engaged in the wholesale, retail and distribution business of Chinese and western medicine, Chinese herbal medicine, medical apparatus, and instruments. The main business of the company is divided into pharmaceutical business sales and the industry of pharmaceutical. The product portfolio of the company includes Corbrin capsule, Cymusi, New Cyspin, Kasiping, Panlisu, Acarbose, and others.

Huadong Medicine Co (SZSE:000963) Headlines

No Headlines